Collagen Supplement Testing in Europe: Why Market Growth Is Outpacing Quality Controls

Collagen supplements are now one of the fastest-selling product categories in European health retail. Almost no one is testing them properly.

The European collagen peptides market was valued at approximately €1.4 billion in 2024 and is forecast to grow at a compound annual rate of 7.8% through 2029. Brands are racing to launch marine collagen capsules, bovine peptide powders, and multi-type complex formulations. Dedicated shelf space at retailers from Monoprix to dm-drogerie markt has expanded substantially. And yet, when we see incoming clients’ quality documentation, the gaps are consistently alarming.

Here’s the core issue: collagen sits in a regulatory grey zone in Europe where there’s no mandatory third-party testing requirement, no specific Ph.Eur. monograph for hydrolyzed collagen peptides, and very limited EFSA guidance on what “quality” actually means for this ingredient. That creates a wide-open door for poor-quality raw materials, mislabeled sources, and outright adulteration — and the brand carries all of the resulting liability.

Why Standard Protein Testing Fails for Collagen

Most European supplement brands test collagen the same way they’d test whey or soy protein: with a Kjeldahl or Dumas nitrogen determination. This tells you total protein content. It tells you nothing about whether the protein is actually collagen.

Collagen is structurally unlike most other dietary proteins. It’s rich in three specific amino acids: glycine (roughly 33% of total amino acid content), proline (~12%), and hydroxyproline (10–12%). Hydroxyproline is the critical marker. It’s almost exclusive to collagen — you’ll find less than 0.5% hydroxyproline in most plant or animal proteins, including common adulterants. So if you run a full amino acid profile and your product shows 10–12% hydroxyproline as a proportion of total amino acids, you have authentic collagen. If it shows 1–2%, you don’t — regardless of what the Kjeldahl result says about total protein.

This matters because a product can pass basic nitrogen testing while being heavily spiked with cheap free amino acids. Glycine costs approximately €2–4 per kilogram in bulk. Manufacturers looking to inflate apparent protein content without paying for genuine collagen peptides can add substantial amounts of glycine, taurine, or creatine — and the total nitrogen number climbs accordingly. This is called nitrogen spiking or protein spiking, and it has been documented across the global collagen category.

A 2021 analysis published in the Journal of Agricultural and Food Chemistry examined commercially available collagen supplements and found that 34% showed amino acid profiles inconsistent with their label claims. In most cases, hydroxyproline levels were well below what authentic hydrolyzed collagen would produce — which the researchers interpreted as evidence of ingredient substitution or dilution.

What EU Regulation Actually Requires — And What It Doesn’t

Under EU Regulation 178/2002 (the General Food Law), collagen supplements must be safe, accurately labeled, and not misleading to consumers. Under Regulation 1169/2011 on food information to consumers, labels must reflect the product’s true composition. That, in broad terms, is the entirety of the enforced quality framework for most collagen products on the European market.

Unlike botanical ingredients, there is no EU positive list specifically governing collagen sources or quality standards. Collagen from traditional bovine, porcine, and fish sources is not classified as a Novel Food under Regulation 2015/2283 — it predates the Novel Food regulatory cutoff — so no pre-market authorization is required. Some marine collagen from non-traditional aquatic species, such as jellyfish, may trigger a Novel Food assessment, but commonly used sources including tilapia, cod skin, and salmon skin are generally considered established ingredients.

EFSA has not authorized any specific health claims for collagen under Regulation 1924/2006. Claims such as “supports skin elasticity” or “promotes joint health” remain unapproved at EU level, so brands typically rely on general nutrition or function claims that dance around the issue. French DGCCRF enforcement, when it does occur, focuses primarily on labeling accuracy and unauthorized health claims — not on analytical verification of the collagen ingredient itself.

The practical implication: a brand can launch a collagen supplement with almost no analytical evidence of identity and still be technically compliant with EU law. That doesn’t mean the risk disappears. It means the brand absorbs it entirely — through consumer complaints, retailer audits, or, increasingly, marketplace platforms demanding testing documentation before allowing listings.

What Rigorous Identity Testing Actually Looks Like

When a collagen raw material comes through our partner-lab qualification process, the protocol covers several distinct layers — and each one catches failures that the others miss.

Amino acid profiling by HPLC is the non-negotiable foundation. A full 17-amino acid profile delivers the hydroxyproline content as a percentage of total amino acids, the glycine-to-proline ratio, and the overall composition fingerprint. This takes approximately 3–5 working days and costs between €150 and €350 per sample in most European contract laboratories. For any authentic Type I or Type II hydrolyzed collagen, hydroxyproline should read between 9% and 13% of total amino acids. Below 7% is a serious flag.

Molecular weight distribution by SDS-PAGE confirms that the hydrolysate has been properly processed. Hydrolyzed collagen peptides should show a distribution centered in the 0.3–8 kDa range. Raw gelatin or insufficiently hydrolyzed material shows significantly higher molecular weights — which affects both claimed bioavailability and practical solubility in finished products. Brands making “high bioavailability” claims on the basis of low molecular weight peptides should have data to support this. Most can’t produce it.

Heavy metal screening is particularly critical for marine collagen, which can concentrate environmental contaminants from the aquatic food chain. Our standard panel covers lead, cadmium, arsenic, and mercury. For marine-sourced material, we’d flag total arsenic above 1.0 mg/kg as a concern regardless of regulatory threshold, because the speciation between organic and inorganic arsenic varies between sample batches and the analytical conversion is not always reliable without further testing.

Species verification is where the science gets genuinely difficult. Once collagen is fully hydrolyzed, DNA is almost entirely degraded, which makes conventional PCR-based species testing unreliable for peptides. Stable isotope ratio analysis (SIRA) and LC-MS/MS peptide mapping using species-specific marker peptides are currently the most defensible approaches for confirming “marine” versus “bovine” or “porcine” sources. These methods are not widely available in European contract labs — one of the principal reasons we operate within a cross-continental partner-lab network, where ISO 17025-accredited facilities in North America have been running these protocols at commercial scale for several years.

The FDA and Health Canada Standard — And What It Should Signal to EU Brands

If you’re selling collagen supplements in Canada under an NPN (Natural Product Number), Health Canada’s Natural Health Products Regulations (SOR/2003-196) require demonstrable evidence of quality, including identification of the medicinal ingredient. For collagen, this means documented identity testing — not simply accepting a supplier’s certificate of analysis as sufficient proof. The US FDA, under 21 CFR Part 111 (Dietary Supplement Current Good Manufacturing Practice), similarly requires finished product manufacturers to verify the identity of each incoming ingredient before use, and explicitly states that relying entirely on a supplier’s COA is non-compliant.

European brands that want to access North American markets encounter this documentation gap immediately. The average time-to-resolution we see is three to six months of additional analytical work — work that proper testing at the raw material qualification stage would have completed in advance.

But it’s worth turning the question around: if both the FDA and Health Canada consider identity testing mandatory as a baseline consumer protection requirement, what does that tell us about the current European framework? Either European consumers are less entitled to verification, or the regulatory environment will eventually catch up. Neither interpretation is comfortable for brands that have been operating without proper quality controls.

Three Things to Do Before Your Next Collagen Launch

Require a full amino acid profile — not just total protein — from every supplier. The COA you receive should show hydroxyproline explicitly, as a percentage of total amino acids, in the 9–13% range. If a supplier provides only a Kjeldahl-based protein figure and can’t back it up with HPLC amino acid data, treat that as a disqualifying factor.

Build independent verification into your raw material program. Supplier COA data is a starting point, not confirmation. Independent testing at an ISO 17025-accredited laboratory — at minimum twice per year per raw material source — provides the analytical independence that both retailer audits and future regulatory requirements will demand. At current European contract lab pricing, this is realistically a €300–700 annual investment per collagen SKU.

Document source traceability in your Product Information File. Under Regulation 1169/2011, labeling must be accurate. If your product is labeled “marine collagen” or “grass-fed bovine collagen,” you need documentation supporting that claim at the batch level. This protects you in a DGCCRF inspection, satisfies retailer due-diligence questionnaires, and positions you correctly for any future market expansion into the US or Canada.

The collagen category isn’t decelerating. European consumers are spending more on these products every year, and new entrants are arriving continuously. The brands that invest in rigorous quality controls now will be materially better positioned when retailer audit requirements tighten, when marketplace testing policies expand beyond Amazon US, and when European regulators eventually take a closer look at a category this large.

Quality documentation is genuinely becoming a competitive advantage. In a market this crowded, it’s also becoming a prerequisite for staying on the shelf.

---

Written by Nour Abochama, Quality & Regulatory Advisor, Care Europe | VP Operations, Qalitex. Learn more about our team

Talk to our team about EU market entry and supplement testing. Contact us

Related from our network

• ISO 17025-Accredited Supplement Identity and Amino Acid Testing in the US — Qalitex Laboratories runs full amino acid profiling, heavy metal screening, and molecular weight distribution testing for North American market entry requirements.
• Health Canada NHP Compliance Testing for Collagen and Marine Supplements — Androxa supports European brands with NHPR-compliant identity testing and NPN documentation for the Canadian market.